Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro. - Archive ouverte HAL Access content directly
Journal Articles PLoS Neglected Tropical Diseases Year : 2011

Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro.

(1) , (1) , (2) , (1) , (1) , (3) , (1) , (1)
1
2
3

Abstract

Here we engineered transgenic Leishmania infantum that express luciferase, the objectives being to more easily monitor in real time their establishment either in BALB/c mice--the liver and spleen being mainly studied-or in vitro. Whatever stationary phase L. infantum promastigotes population--wild type or engineered to express luciferase-the parasite burden was similar in the liver and the spleen at day 30 post the intravenous inoculation of BALB/c mice. Imaging of L. infantum hosting BALB/C mice provided sensitivity in the range of 20,000 to 40,000 amastigotes/mg tissue, two tissues-liver and spleen-being monitored. Once sampled and processed ex vivo for their luciferin-dependent bioluminescence the threshold sensitivity was shown to range from 1,000 to 6,000 amastigotes/mg tissue. This model further proved to be valuable for in vivo measurement of the efficiency of drugs such as miltefosine and may, therefore, additionally be used to evaluate vaccine-induced protection.
Fichier principal
Vignette du fichier
journal.pntd.0001323.pdf (1.46 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-00691453 , version 1 (26-04-2012)

Identifiers

Cite

Grégory Michel, Bernard Ferrua, Thierry Lang, Madhavi P. Maddugoda, Patrick Munro, et al.. Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro.. PLoS Neglected Tropical Diseases, 2011, 5 (9), pp.e1323. ⟨10.1371/journal.pntd.0001323⟩. ⟨inserm-00691453⟩
121 View
251 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More